Other SNPs with increased cancer susceptibility include FCGR2A H166R (rs1801274) associated with increased risk for non-Hodgkin’s lymphoma[51], ANKK1 E713K (rs1800497;[52]) involved in advanced adenoma recurrence, HNF1A S487N (rs2464196;[53]), MMP9 Q166R (rs17576-rs2250889;[54]), and XPC Q939K (rs2228001;[55]) variants associated with lung cancer, ATG16L1 T137A (rs2241880;[56,57]) with Crohn’s disease, and OGG1 P332A (rs1052133;[58-60]) associated with bladder and gall-bladder cancer in Japanese, Chinese and Indian populations. This evidence concerns the gene FCGR2A and non-Hodgkin lymphoma.